Market access remains one of the most significant current and future challenges for the industry. Spiralling drug development costs exert pressure to ensure successful and effective planning of your access strategies. With up to $5 billion in R&D costs for every successful drug launched, winning strategies are critical. Understanding the strengths and shortcomings in your people, processes and evidence are going to be the keys to your success. Planning around these key factors will enable increased market share for your organisation.
This year's conference will be held on 13-14 October. Now in its 20th year, this event has been one of the oldest market leaders in the pharmaceutical industries calendar for some time. Our expert speaking faculty; made up from key industry personnel from big pharma, biotech and academia will thoroughly explain and offer advice on P&R and market access. The 2014 agenda will focus on case studies as applied to different countries and environments in terms of market access.
Chairs for 2014:
• Peter Hertzman, Nordic Market Access Director, BMS
• Leslie Galloway, Chairman, Ethical Medicines Industry Group (EMIG)
Key Speakers Include:
• Leyla Hannbeck, Head of Pharmacy Services, National Pharmacy Association
• Silke Baumann, Head of Unit, Pricing, Assessment and Reimbursement of New Medicines, Ministry of Health, Germany
• Rodolphe Perard, Associate Director, Market Access, Gilead
• Francois Bernard, Head of Market Access, Mundipharma
• Mike Chambers, Head of Reimbursement and Value, Market Access and Healthcare Solutions, GlaxoSmithKline
• Linda Van Saase, Manager, Pharmaceutical Care, National Healthcare Institute
• Irma Van Den Arend, VP, Global Pricing, Reimbursement and Funding, Ipsen
• Mete Saylan, Senior Market Access Manager, Novartis
Benefits of Attending:
• Evaluate challenges within price discrimination
• Implications of AMNOG featuring IGES institut, EUCOPE and Ministry of Health, Germany
• Case study from Ipsen on latest developments in pharmaceutical pricing
• Analyse the impact of Value Based Assessment on SMEs
• Gain further insight on how to engage effectively with payers
• Key presentation on the IMI GetReal Consortium
• Ample networking opportunities , including a drinks reception on the close of Day One sponsored by Quintiles
Benefit from the Early Bird Discounts:
Save £300 if you book by 30th June 2014
Save £100 if you book by the 18th July 2014
To book and for full programme details please visit:
http://www.smi-online.co.uk/2014europricing43.asp> For Delegate Registrations please contact:
John Collins on 44(0) 207 827 6734 | jcollins@smi-online.co.uk
> For press passes and for media partnerships please contact:
Daniel Lee on 44(0) 207 827 6078 | dlee@smi-online.co.uk
Venue:
Marriott Hotel Regents Park
Location: London
Country: United Kingdom
Organiser Contact Details:
Daniel LeeT:
+44(0) 207 827 6078dlee@smi-online.co.uk
